Article Text
PDFReview
Can I treat this pregnant patient with botulinum toxin?
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Ralph Gregory, Poole, UK.
Linked Articles
- Editors' choice
Read the full text or download the PDF:
Other content recommended for you
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up
- A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia
- Botulinum toxin in clinical practice
- British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
- Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis
- Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
- Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®